Content area

|
|

Patofysiologiske aspekter ved statiners diabetogene effekt

Forfatter(e)
Sascha Pilemann-Lyberg, Anette Bratt Solis & Peter Gæde Medicinsk Afdeling, Slagelse Sygehus Ugeskr Læger 2014;176:V02130103
Reference: 
Ugeskr Læger 2014;176:V02130103
Blad nummer: 
Sidetal: 
223-227
Pathophysiological aspects of the diabetogenic effect of statins
Statins are potent inhibitors of cholesterol biosynthesis. Statins are beneficial in the primary and secondary prevention of coronary heart disease. Recent studies indicate that there is an association between statin use and the development of new-onset diabetes mellitus. This article reviews the patophysiological mechanisms by different statins to explain this association.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Frederik Winsløw | 22/01
2 kommentarer
af Helle Borgstrøm | 22/01
10 kommentarer
af Martin Lindhardt Nielsen | 22/01
1 Kommentar
af Kurt Håkonsson | 19/01
4 kommentarer
af Erik Kristensen | 17/01
20 kommentarer
af Thomas Michael Dan Aru | 17/01
4 kommentarer